Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Hypertriglyceridemia (Disease Or Phenotype)

Msh:D015228

Mondo:MONDO:5347

Medcin:MEDCIN:394443

Mdr:MDR:10054411

Id:b711373d-e1bb-5e0b-a08b-a6015353c803

Icpc2icd10eng:MTHU036194

Efo:EFO:4211

Chv:CHV:6455

Results found

Linked to

	Label	Description
	fenofibrate indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	monacolin K indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	simvastatin indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	gemfibrozil indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	ciprofibrate indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Icosapent ethyl indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(E)-(3R,5S)-7-[4-(4-Fluoro-phenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid anion indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Choline fenofibrate indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pravastatin indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	atorvastatin indication Hypertriglyceridemia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

fenofibrate indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

monacolin K indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

simvastatin indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

gemfibrozil indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

ciprofibrate indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Icosapent ethyl indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(E)-(3R,5S)-7-[4-(4-Fluoro-phenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid anion indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Choline fenofibrate indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Pravastatin indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

atorvastatin indication Hypertriglyceridemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.